您使用提示模式 关闭

HELX - Franklin Genomic Advancements ETF (USD) (US35473P5200)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
US35473P5200
HELX ISIN
交易所交易基金 (ETF)
基金类型
Franklin Templeton Investments
提供商
39,53 USD
每股资产净值 | 2026-07-17
2020-02-25
成立日期
1 每年的次数
股息的支付
CEOJLS
CFI
HELX
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
Russell 3000 Index
基准
0.5 %
总成本比率
29,65 百万 USD
基金资产总量 | 2026-07-17
29,65 百万 USD
股票类资产 | 2026-07-17
否
UCITS

收益率 在 2026-07-17, Cboe BZX Exchange

  • YTD
    -10,83 %
  • 1M
    -6,62 %
  • 3M
    -7,6 %
  • 6M
    -7,55 %
  • 1Y
    24,21 %
  • 3Y
    9 %
  • 5Y
    -21,11 %
  • 10Y
    -
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (HELX)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

HELX profile

The Franklin Genomic Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Franklin Templeton Investments fund’s base currency is USD and the share class was registered 25.02.2020 with unique ISIN - US35473P5200. Main exchange is Cboe BZX Exchange and ticker symbol is HELX. The total expense ratio is 0.5%. The Franklin Genomic Advancements ETF (USD) pays dividends 1 time(s) per year.

结构 HELX 在 2026-07-16

下载结构至 Excel 文档
证券 值
GUARDANT HEALTH INC GH 9,54%
NATERA INC NTRA 7,53%
KRYSTAL BIOTECH INC KRYS 5,91%
LIGAND PHARMACEUTICALS LGND 4,4%
ADAPTIVE BIOTECHNOLOGIES ADPT 4,17%
BRIDGEBIO PHARMA INC BBIO 3,83%
UNITED THERAPEUTICS CORP UTHR 3,48%
ELI LILLY & CO LLY 2,92%
VERTEX PHARMACEUTICALS IN VRTX 2,73%
TWIST BIOSCIENCE CORP TWST 2,57%
TRAVERE THERAPEUTICS INC TVTX 2,56%
INSMED INC INSM 2,5%
ASTRAZENECA PLC AZN 2,45%
SAMSUNG BIOLOGICS CO LTD 207940 2,41%
CORTEVA INC CTVA 2,34%
MEDPACE HOLDINGS INC MEDP 2,21%
CASH — 2,1%
REGENERON PHARMACEUTICALS REGN 1,99%
NEUROCRINE BIOSCIENCES IN NBIX 1,91%
ALNYLAM PHARMACEUTICALS I ALNY 1,87%
TEMPUS AI INC-CL A TEM 1,83%
VERACYTE INC VCYT 1,68%
ARGENX SE ARGX 1,54%
PTC THERAPEUTICS INC PTCT 1,43%
BIONTECH SE-ADR BNTX 1,38%
IONIS PHARMACEUTICALS INC IONS 1,34%
CHARLES RIVER LABORATORIE CRL 1,3%
STOKE THERAPEUTICS INC STOK 1,2%
CAREDX INC CDNA 1,17%
GRAIL INC GRAL 1,17%
REPLIGEN CORP RGEN 1,08%
CADENCE DESIGN SYS INC CDNS 0,96%
SARTORIUS AG-VORZUG SRT3 0,93%
CRISPR THERAPEUTICS AG CRSP 0,89%
ANAPTYSBIO INC ANAB 0,84%
IQVIA HOLDINGS INC IQV 0,83%
THERMO FISHER SCIENTIFIC TMO 0,83%
AXSOME THERAPEUTICS INC AXSM 0,81%
PRAXIS PRECISION MEDICINE PRAX 0,8%
JAZZ PHARMACEUTICALS PLC JAZZ 0,8%
BEAM THERAPEUTICS INC BEAM 0,78%
HINGE HEALTH INC-A HNGE 0,73%
DANAHER CORP DHR 0,63%
AGILENT TECHNOLOGIES INC A 0,6%
ULTRAGENYX PHARMACEUTICAL RARE 0,56%
QIAGEN N.V. — 0,52%
ARCUTIS BIOTHERAPEUTICS I ARQT 0,45%
RHYTHM PHARMACEUTICALS IN RYTM 0,4%
FIRST TRACKS BIOTHERAPEUT TRAX 0,37%
SAMSUNG EPISHOLDINGS CO L 0126Z0 0,36%
KINIKSA PHARMACEUTICALS I KNSA 0,33%
BIO-RAD LABORATORIES-A BIO 0,27%
BRISTOL-MYERS SQUIBB CO BMY 0,26%
NEUROGENE INC NGNE 0,26%
BEONE MEDICINES LTD-ADR ONC 0,26%
TG THERAPEUTICS INC TGTX 0,25%
LIQUIDIA CORP LQDA 0,24%
TARSUS PHARMACEUTICALS IN TARS 0,24%
GENEDX HOLDINGS CORP WGS 0,13%
WAVE LIFE SCIENCES LTD WVE 0,1%
RECURSION PHARMACEUTICALS RXRX 0,06%
OMNIAB INC - 15.00 EARNOU 2200964 0%
OMNIAB INC - 12.5 EARNOUT 2200963 0%
Net Current Assets — -0,02%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权